GSK’s cancer drug combination meets primary goal
GSK said on Monday that a combination of its cancer drugs Zejula and Jemperli, when… Read More
10 months ago
GSK
Arexvy: GSK’s common respiratory virus vaccine shows potential
GSK said Arexvy, its vaccine for respiratory syncytial virus (RSV) showed positive preliminary results in… Read More
11 months ago
Zhifei: China’s largest vaccines company will pay GSK 2.5 billion pounds
China's largest vaccines company Zhifei will pay British drugmaker GSK 2.5 billion pounds ($3.05 billion… Read More
12 months ago
GSK, Novartis pledge funds for diseases that mostly affect the poor
GSK and Novartis on Thursday reinforced commitments to address neglected tropical diseases, as world leaders… Read More
2 years ago
Unilever’s offer for GSK’s consumer health raises doubts
Unilever faces a dilemma after its 50 billion pound ($68 billion) offer for GlaxoSmithKline's consumer… Read More
3 years ago
US secures 600,000 more doses of COVID-19 therapy Sotrovimab
The United States has agreed to buy 600,000 more doses of GSK and Vir Biotechnology's… Read More
3 years ago
New data shows GSK-Vir drug works against all Omicron mutations
British drugmaker GSK said on Tuesday its antibody-based COVID-19 therapy with U.S. partner Vir Biotechnology… Read More
3 years ago
GSK, CureVac’s next-gen COVID-19 vaccine shows promise
GlaxoSmithKline and CureVac said a study on macaque monkeys showed their jointly-developed mRNA COVID-19 vaccine… Read More
3 years ago
GSK drug shows promise as treatment in kidney disease patients
GSK said on Friday its anaemia drug for patients with kidney disease succeeded in late-stage… Read More
3 years ago
Sanofi, GSK get Indian approval for trial of COVID-19 vaccine
Sanofi and GlaxoSmithKline have received an approval from Indian authorities for a late-stage clinical trial… Read More
3 years ago
Sanofi, GSK launch final phase of Covid vaccine trials
The companies reported positive results from interim human trials earlier this month after a disappointing… Read More
3 years ago
GSK buys 10% of CureVac in vaccine tech deal
GSK and CureVac, backed by Microsoft billionaire Bill Gates, will work on developing up to… Read More
4 years ago
Britain nears US$625 million Sanofi/GSK COVID-19 vaccine deal: report
Britain is close to a 500 million pound ($624 million) supply deal with Sanofi and… Read More
4 years ago
World’s largest vaccine maker reveals COVID-19 vaccine plans
There is a notable name missing from the frontrunners in the race to test experimental… Read More
4 years ago
GSK to produce 1 billion doses of vaccine efficacy boosters
The world’s largest vaccine maker said it was in talks with governments to back a… Read More
4 years ago
GSK ends development of Ebola vaccine
While Ebola is a deadly and contagious disease, it is also still relatively rare, making… Read More
5 years ago
HIV drug wins European panel thumbs-up
GlaxoSmithKline’s two-drug treatment for HIV infections won marketing approval from a European Medicines Agency (EMA) Read More
5 years ago
GSK, Pfizer to merge consumer healthcare units
LONDON: Pharmaceutical giants GlaxoSmithKline and Pfizer on Wednesday announced a merger of their consumer healthcare… Read More
6 years ago
GSK ‘real world’ drug test has second success in asthma
LONDON: GlaxoSmithKline notched up a second win for its pioneering "real world" approach to testing… Read More
7 years ago
Gilead challenges GSK with strong HIV drug data
SEATTLE: Gilead Sciences has thrown down a challenge to GlaxoSmithKline with good clinical trial results… Read More
8 years ago